Cargando…
Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis
A 29-year-old man with advanced hilar cholangiocarcinoma was successfully treated with an extended right lobectomy. The carbohydrate antigen 19-9 (CA19-9) level was elevated to 939 IU/l, and the pathological findings revealed moderately differentiated tubular adenocarcinoma which involved almost the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929407/ https://www.ncbi.nlm.nih.gov/pubmed/20805936 http://dx.doi.org/10.1159/000313791 |
_version_ | 1782185923367141376 |
---|---|
author | Suehiro, Taketoshi Matsumata, Takashi Iguchi, Tomohiro Sanefuji, Kensaku Nomoto, Ken-ichi Taketomi, Akinobu Shirabe, Ken Maehara, Yoshihiko |
author_facet | Suehiro, Taketoshi Matsumata, Takashi Iguchi, Tomohiro Sanefuji, Kensaku Nomoto, Ken-ichi Taketomi, Akinobu Shirabe, Ken Maehara, Yoshihiko |
author_sort | Suehiro, Taketoshi |
collection | PubMed |
description | A 29-year-old man with advanced hilar cholangiocarcinoma was successfully treated with an extended right lobectomy. The carbohydrate antigen 19-9 (CA19-9) level was elevated to 939 IU/l, and the pathological findings revealed moderately differentiated tubular adenocarcinoma which involved almost the entire thickness of the hepatic duct and the adjacent liver tissue (T3) and which was associated with lymph node metastasis (N1). It was a stage IIB (T3N1M0) tubular adenocarcinoma according to UICC pathological staging. Immunohistochemical examination revealed that Ki-67, cyclin D1, and MMP-7 were positive, and 14-3-3σ and p27 were negative. The pathological and immunohistochemical findings indicated high malignant potential indicating poor prognosis. We administrated the postoperative adjunct gemcitabine combined with S-1 chemotherapy. The patient is alive without recurrence and doing well two years after surgery. We also review other reports of cholangiocarcinoma patients aged less than 30 years. |
format | Text |
id | pubmed-2929407 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-29294072010-08-30 Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis Suehiro, Taketoshi Matsumata, Takashi Iguchi, Tomohiro Sanefuji, Kensaku Nomoto, Ken-ichi Taketomi, Akinobu Shirabe, Ken Maehara, Yoshihiko Case Rep Gastroenterol Published: May 2010 A 29-year-old man with advanced hilar cholangiocarcinoma was successfully treated with an extended right lobectomy. The carbohydrate antigen 19-9 (CA19-9) level was elevated to 939 IU/l, and the pathological findings revealed moderately differentiated tubular adenocarcinoma which involved almost the entire thickness of the hepatic duct and the adjacent liver tissue (T3) and which was associated with lymph node metastasis (N1). It was a stage IIB (T3N1M0) tubular adenocarcinoma according to UICC pathological staging. Immunohistochemical examination revealed that Ki-67, cyclin D1, and MMP-7 were positive, and 14-3-3σ and p27 were negative. The pathological and immunohistochemical findings indicated high malignant potential indicating poor prognosis. We administrated the postoperative adjunct gemcitabine combined with S-1 chemotherapy. The patient is alive without recurrence and doing well two years after surgery. We also review other reports of cholangiocarcinoma patients aged less than 30 years. S. Karger AG 2010-05-12 /pmc/articles/PMC2929407/ /pubmed/20805936 http://dx.doi.org/10.1159/000313791 Text en Copyright © 2010 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions. |
spellingShingle | Published: May 2010 Suehiro, Taketoshi Matsumata, Takashi Iguchi, Tomohiro Sanefuji, Kensaku Nomoto, Ken-ichi Taketomi, Akinobu Shirabe, Ken Maehara, Yoshihiko Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis |
title | Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis |
title_full | Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis |
title_fullStr | Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis |
title_full_unstemmed | Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis |
title_short | Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis |
title_sort | immunohistochemical examination of a resected advanced hilar cholangiocarcinoma arising in a 29-year-old male without primary sclerosing cholangitis |
topic | Published: May 2010 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929407/ https://www.ncbi.nlm.nih.gov/pubmed/20805936 http://dx.doi.org/10.1159/000313791 |
work_keys_str_mv | AT suehirotaketoshi immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis AT matsumatatakashi immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis AT iguchitomohiro immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis AT sanefujikensaku immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis AT nomotokenichi immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis AT taketomiakinobu immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis AT shirabeken immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis AT maeharayoshihiko immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis |